INSIDE PHARMA

INSIDE PHARMA

Share this post

INSIDE PHARMA
INSIDE PHARMA
FDAs regulatory revolving doors could be more prominent than we know...

FDAs regulatory revolving doors could be more prominent than we know...

Has it become an epidemic, even a pandemic?

Hedley Rees's avatar
Hedley Rees
Jun 26, 2024
∙ Paid
11

Share this post

INSIDE PHARMA
INSIDE PHARMA
FDAs regulatory revolving doors could be more prominent than we know...
9
3
Share

Engaged subscriber Alan Richards makes an excellent point

In the post below, Alan Richards got me thinking with his comment:

“Presumably because they’re not sociopathic careerists like PM [Peter Marks]. According to LinkedIn Krause has been an independent consultant since December 2021.”

Why did Dr. Marion Gruber, director of the Office of Vaccines Research and Review and Dr. Philip Krause, deputy director of the office, leave FDA in 2021?

Why did Dr. Marion Gruber, director of the Office of Vaccines Research and Review and Dr. Philip Krause, deputy director of the office, leave FDA in 2021?

Hedley Rees
·
June 24, 2024
Read full story

But, while they may not be sociopathic careerists, could they be furthering profitable careers according to the principle of revolving doors?

This is Marion Gruber’s next appointment:

NEW YORK – JANUARY 18, 2022 – IAVI is very pleased to announce the appointment of Marion F. Gruber, Ph.D., M.S., as Vice President, Public Health and Regulatory Science:

IAVI Welcomes Marion F. Gruber as Vice President, Public Health and Regulatory Science

We learn:

“Dr. Gruber also contributed to global vaccine development, policy, and safety oversight by serving as expert advisor to the World Health Organization (WHO) and as a member of the WHO Global Advisory Committee on Vaccine Safety”

This is Philip Krause’s next appointmen…

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 Hedley Rees
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share